Table 1.

Characteristics of included studies

Study ID	GPs (n*)	Patient population	Prevention		Risk		Conceptual methodological framework	Data collection	Analysis	CVD prevention topic area and scope
			Primary	Secondary	Absolute	Relative
Australia
Bonner et al, 201325	25	General	NS		●		Phenomenological	Semistructured interview	Framework analysis	Risk assessment
Bonner et al, 201427	25	General	NS		●		Qualitative	Semistructured interview	Framework analysis	Risk assessment
Bonner et al, 201533	25	General	NS		●		Qualitative	Semistructured interview	Framework analysis	Risk assessment
Liu et al, 201566	25	Indigenous	●		●		Qualitative	Semistructured interviews	Thematic analysis	Medication
Pomeroy and Worsley, 200823	30	General	NS		NS		Multi methods	Semistructured interviews and questionnaire	Conceptual analysis	Lifestyle change
Speechly et al, 201030	8	Primary coronary heart disease		●	●		Qualitative	Semistructured interviews	Thematic analysis	Lifestyle change/medication
Volker et al, 201726	11	General	●		●		Qualitative	Semistructured interviews	Framework analysis	Risk assessment
Wan et al, 200867	22	High-risk CV factor	●		●		Qualitative	Focus groups and semistructured interview	Thematic analysis	Risk assessment
Wan et al, 201028	22	High-risk CV factor	●		●		Qualitative	Focus groups	Thematic analysis	Risk assessment
France
Lebeau et al 201640	125	High-risk hypertensive	●		NS		Qualitative	Open-ended questionnaire	Thematic analysis	Medication
Guatemala
Montano et al, 200868		General	NS		NS		Qualitative	Focus group discussions and in-depth interviews	Thematic analysis	Lifestyle change
The Netherlands
Nielen et al, 201069	330	General	●		NS		Qualitative	Open-ended questionnaire	Thematic analysis	Lifestyle change
New Zealand
Doolan-Noble et al, 201231	29	High CVD risk	●		●		Qualitative	Focus group	Thematic analysis	Barriers and facilitators
Sapre et al, 200970	20	Primary myocardial infarction		●	●	●	Qualitative	Semistructured interview	Conceptual analysis	Medication
Torley et al, 200571	36	General	●		●		Qualitative	Focus groups	Thematic analysis	Risk assessment
Weiner et al, 200972	86	Older people	NS		●		Qualitative	Questionnaire	Thematic analysis	Risk assessment and management
Scotland
Fairhurst and Huby, 199824	24	General	●	●	NS		Qualitative	Semistructured interview	NS	Medication
Sweden
Fharm et al, 200934	14	Type 2 diabetes	NS		NS		Qualitative	Focus group	Qualitative content analysis	Lifestyle changes/medication
Silwer et al, 201020	21	General	●		●		Qualitative	Semistructured interview	Thematic analysis	Medication
Wahlstrom et al, 199773	20	General	●	●	NS		Phenomenological	Semistructured Interview	Conceptual analysis	Medication
UK
Fisseni et al, 200874	6	General	NS		●		Qualitative	Semistructured interview	Qualitative content analysis	Risk assessment
Gale et al, 201122	13	General	●		●	●	Qualitative	Semistructured interview	Thematic analysis	Medication
Greenfield et al,200519	192	General	NS		NS		Qualitative	Closed question postal questionnaire with free-text comments	Thematic analysis	Medication
Kedward and Dakin, 200332	26	General	●	●	NS		Qualitative	Semistructured interview	Thematic analysis	Medication
Lewis et al, 200375	4	General	NS		●		Qualitative	Semistructured interview	Thematic analysis	Medication
Liew et al, 201376	20	General	●		●	●	Qualitative	Face-to-face semistructured interviews	Thematic analysis	Risk assessment
Macintosh et al, 200377	18	Primary coronary heart disease		●	NS		Qualitative	Semistructured interviews	Conceptual analysis	Nurse-led clinics
Summerskill and Pope, 200278	14	Secondary coronary heart disease		NS	NS		Qualitative	Semistructured interviews	Thematic analysis	Barriers and facilitators
Virdee et al, 2009, 201379	11	General	●	●	NS		Qualitative	Semistructured interview	Thematic analysis	Medication
Williams and Calnan, 199429	40	General	●	●	NS		Qualitative	In-depth interview	Thematic analysis	Lifestyle change/medication
Wright et al, 200680	10	Severe mental illness	●		NS		Qualitative	In-depth interviews	Thematic analysis	Lifestyle change/medication
USA
Bartels et al, 201621	9	Rheumatoid arthritis	NS		NS		Qualitative	Semistructured interview	Grounded theory	Risk assessment and management
Rosal et al, 200481	11	High-risk coronary heart disease	NS		●		Qualitative	Focus groups	Thematic analysis	Lifestyle change/medication
Tanner et al, 201782	23	Secondary coronary heart disease		●	NS		Qualitative	Group interviews	Thematic analysis	Medication

*n=GPs (including primary care physicians); ●, type of prevention and risk specified in the study.

CV, cardiovascular; CVD, cardiovascular disease; GPs, general practitioners; NS, not stated.